关键信息
-
基因名
EphB2
- 应用
-
别名
CAPB; DRT; EPHT3; ERK; Hek5; PCBC; Tyro5; Developmentally-regulated Eph-related tyrosine kinase; ELK-related tyrosine kinase; EPH-like kinase 5; EPH tyrosine kinase 3
-
种属
Human
-
表达系统
E. coli
-
标签
Two N- s, His- & SUMO-
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P29323
-
表达区间
Val19~Leu543
-
蛋白长度
Partial
-
分子量
70kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
EphB2 is a member of the Eph receptor tyrosine kinase family, which plays a crucial role in various biological processes, including cell signaling, tissue development, and neural network formation. Dysregulation of EphB2 has been implicated in several pathological conditions, particularly in cancer, where it can influence tumor growth, metastasis, and the tumor microenvironment. This makes EphB2 a compelling target for therapeutic interventions. Research on recombinant EphB2 proteins has gained traction as a means of understanding the precise mechanisms by which EphB2 interacts with its ligands, primarily ephrins, and mediates cellular responses. By studying the structure and functional characteristics of EphB2 in a recombinant form, scientists can elucidate the signaling pathways involved and identify potential biomarkers for cancer diagnosis and prognosis. Furthermore, the production of recombinant EphB2 offers opportunities for drug design and targeted therapies that could modulate its activity, providing avenues for innovative cancer treatments. Understanding the EPHB2-ephrins interaction at the molecular level may also lead to insights into more complex physiological processes, including angiogenesis and neurogenesis, thereby expanding the significance of this receptor beyond oncology. Overall, the ongoing research on recombinant EphB2 proteins not only enhances our foundational knowledge of cellular communication but also holds promise for the development of novel therapeutic strategies against cancer and other diseases associated with EphB2 dysfunction.
